A Randomized Controlled Trial To Evaluate the Immunogenicity of Two Doses of the Modified Killed Whole-Cell Oral Cholera Vaccine Under Two Alternative Vaccination Schedules.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Pharmacodynamics
- 21 Aug 2012 Planned End Date changed from 1 Dec 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov record.
- 21 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 29 Mar 2012 Planned end date changed from 1 Nov 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.